Joaquin Arribas

发表

Early-Stage Breast Cancer Detection in Breast Milk

J. Tabernero, P. Nuciforo, R. Dienstmann, 2023, Cancer discovery.

AXL - a new player in resistance to HER2 blockade.

A. Adam-Artigues, J. Cejalvo, E. J. Arenas, 2023, Cancer treatment reviews.

Pancreatic cancer heterogeneity and response to Mek inhibition

J. Tabernero, J. Arribas, A. Vivancos, 2017, Oncogene.

The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models

R. Dienstmann, O. Díez, S. Gutiérrez‐Enríquez, 2024, Genome medicine.